| III-37 Evelina Cardoso Population pharmacokinetic analysis of erlotinib in cancer patients affected by NSCLC Thursday 09:55-11:30 |
| III-37 Evelina Cardoso Population pharmacokinetic analysis of erlotinib in cancer patients affected by NSCLC Thursday 09:55-11:30 |